Introduction {#sec1}
============

"*Leucobacter massiliensis*" strain 122RC15^T^ (= DSM 29913= CSUR P1430) is the type strain of *L. massiliensis* sp. nov. This bacterium was isolated from the pharynx of a 76-year-old woman originating from Algeria and living in Marseille after travelling from the 2014 Hajj [@bib1]. This pilgrim had respiratory tract symptoms including cough, sore throat and loss of voice but without antibiotic usage during the Hajj. The genus *Leucobacter* was first designed by Takeuchi et al. [@bib2] and formerly included 25 validly described species. Members of *Leucobacter* have been isolated from several sources including waste-water [@bib3], [@bib4], [@bib5], [@bib6], [@bib7], soil environments [@bib8], [@bib9], air [@bib10], foods [@bib11] and nematodes [@bib12]. However, there are no known human pathogens among the genus *Leucobacter.*

"*L. massiliensis*" is an aerobic, Gram-positive bacillus. With current knowledge, this strain 122RC15 is the first species of *Leucobacter* genus isolated from human pharynx. Here, we describe the main characteristics of strain 122RC15 with a phenotypic and phylogenetic analysis and the complete genome description.

Materials and methods {#sec2}
=====================

Strain identification {#sec2.1}
---------------------

A pharyngeal sample was obtained from a healthy pilgrim after travelling to the 2014 Hajj. The pharyngeal sample was processed as previously described [@bib1]. This strain was isolated by cultivation on Chocolate agar PolyViteX (bioMérieux, Marcy l'Étoile, France) under a 5% CO~2~ atmosphere at 37°C after 1 day of incubation. For bacterial identification, matrix-assisted laser desorption--ionization time-of-flight mass spectrometry (MALDI-TOF-MS) protein analysis was carried out as previously described [@bib13]. The 122RC15 spectra were imported into MALDI [BioTyper]{.smallcaps} 3.0 software (Bruker Daltonics, Leipzig, Germany) and analysed by standard pattern matching (with default parameter settings) against 7765 spectra of bacteria. From the resulting scores, the tested strain may or may not be identified compared with the instrument\'s database; a score of ≥2 with a validly published species enabled identification at the species; a score ≥1.7 and \<2 allows identification at the genus level; and a score \<1.7 does not enable any identification.

Phylogenetic analysis and classifications {#sec2.2}
-----------------------------------------

The 16S rRNA gene was sequenced as previously described [@bib14]. The 16S rRNA gene sequence was blasted to the NCBI database for species identification. The strain is considered as a new species if the percentage of similarity is \<98.7%. For phylogenetic classification, homologous sequences from type strains found on the List of Prokaryotic Names with Standing in Nomenclature (LPSN) website (<http://www.bacterio.net/>) were downloaded from the NCBI database. The phylogenetic tree was constructed using a neighbour-joining method and the maximum composite likelihood substitution model with 1000 bootstraps on MEGA6 (Molecular Evolutionary Genetics Analysis) software [@bib15].

Phenotypic properties and biochemical characterization {#sec2.3}
------------------------------------------------------

Growth of the strain was tested under aerobic conditions with or without 5% CO~2~ including anaerobic and microaerophilic conditions using GENbag anaer and GENbag microaer systems, respectively (bioMérieux) with different temperatures (25°C, 30°C, 37°C, 42°C and 45°C). Optimal salt concentration was determined by growing the strain at 0%, 0.5%, 2%, 7% and 10% NaCl. Gram staining, motility and sporulation were observed using a light microscope (DM1000; Leica Microsystems, Nanterre, France). Electron microscopy of "*L. massiliensis*" was performed using a TechnaiG2 Cryo (FEI Company, Limeil-Brevannes, France) at an operating voltage of 200 keV.

Biochemical assays were characterized using API ZYM and API 50 CH (bioMérieux) gallery systems. Cellular fatty acid methyl ester analysis was performed by gas chromatography/mass spectrometry as previously described [@bib16].

Genome sequencing and assembly {#sec2.4}
------------------------------

Genomic DNA of "*L. massiliensis*" was sequenced using the MiSeq Technology (Illumina, San Diego, CA, USA) with the pair end and mate-pair strategies. First, automated cluster generation and sequencing runs were performed in a single 39-h run at a 2 × 250-bp read length. Total information of 7.3 Gb was obtained from an 800 K/mm^2^ cluster density, with a cluster passing quality control filters of 92.2% (14 034 000 passing filter clusters). Within this run, the index representation for "*L. massiliensis*" was 10.25%. The 1 438 190 paired reads were trimmed. Moreover, two mate-pair libraries were performed in a single 39-h run in a 2 × 151-bp read length. The first library was loaded twice in the same run where total information of 6.1 Gb was obtained from a 653 K/mm^2^ cluster density with a cluster passing quality control filters of 96.1% (12 031 000 passing filter paired reads). Within this run, the index representation for "*L. massiliensis*" was 4.29%. The 978 060 paired reads were trimmed then assembled. The second library was loaded once and 6.5 Gb of total information was obtained from a 696 K/mm^2^ cluster density with a cluster passing quality control filters of 95.6% (12 863 000 passing filter paired reads). Within this run, the index representation for "*L. massiliensis*" was determined at 8.04%. The 976 328-paired reads were trimmed. The assembly of the three runs leaded to 3 392 578 paired end reads. SPA[des]{.smallcaps} assembler was used and assembled in to 24 scaffolds.

Genome annotation and comparisons {#sec2.5}
---------------------------------

Open reading frames were predicted using [Prodigal]{.smallcaps} (<http://prodigal.ornl.gov/>) with default parameters. The predicted open reading frames were excluded if they spanned a sequencing gap region. The predicted protein sequences were searched against the GenBank [@bib17] and Clusters of Orthologous Groups database (COGs) databases using B[last]{.smallcaps}P. The tRNAScanSE tool [@bib18] and RNAmmer [@bib19] were used to find tRNA genes and ribosomal RNAs, respectively. Signal peptides and transmembrane helices were predicted by S[ignal]{.smallcaps}P [@bib20] and TMHMM [@bib21]. Furthermore, mobile genetic elements were predicted using PHAST [@bib22] and RAST server [@bib23]. The resistome analysis was identified with the ARG-ANNOT database [@bib24]. Analysis of the presence of polyketide synthases/non-ribosomal peptide synthetases and bacteriocins was identified as previously described [@bib25]. Genomic islands were predicted by [IslandViewer]{.smallcaps} [@bib26]. The genome sequences of available species in the genus *Leucobacter* were downloaded from NCBI. Average nucleotide identity of draft genomes within the *Leucobacter* genus was calculated by pairwise comparisons using [JSpeciesWS]{.smallcaps} [@bib27]. Moreover, proteome comparisons were performed by CMG-[biotools]{.smallcaps} [@bib28] with minimum query coverage of 50% and minimum identity of 50%.

Results {#sec3}
=======

Phylogenetic analysis {#sec3.1}
---------------------

After isolation of strain 122RC15, identification was performed by MALDI-TOF analysis. However, MALDI-TOF-MS was unable to identify the strain 122RC15 because its spectrum was not part of the database. [Blast]{.smallcaps} results for 16S rRNA gene sequences showed 98.3% similarity with *Leucobacter kyeonggiensis* strain F3-P9 (GenBank Accession no. NR132679.1), which was confirmed by phylogenetic tree construction ([Fig. 1](#fig1){ref-type="fig"}). Hence, we propose the creation of a new species, which putatively classifies it as a member of the *Leucobacter* genus within the *Microbacteriaceae* family in the *Actinobacteria* phylum ([Table 1](#tbl1){ref-type="table"}). The 16S rRNA sequence was deposited in NCBI under GenBank Accession no. LN849775.Fig. 1Phylogenetic tree showing relationship of *Leucobacter massiliensis* strain 122RC15 (circle remark) to most closely related species and other representative members of genus *Leucobacter*. The GenBank Accession numbers for 16S rRNA genes are in parenthesis. Tree was constructed using neighbour-joining method and the maximum composite likelihood substitution model with 1000 bootstraps.Table 1Classification and general features of *Leucobacter massiliensis* strain 122RC15PropertyTermCurrent classificationDomain: *Bacteria*\
Phylum: *Actinobacteria*\
Class: *Actinobacteria*\
Order: *Micrococcales*\
Family: *Microbacteriaceae*\
Genus: *Leucobacter*\
Species: *Leucobacter massiliensis*\
122RC15Gram stainGram-positive bacillusCell shapeIrregular rod-shapedMotilityNon-motileSporulationNon-endospore formingSalinity0%--10% NaCl (weight/volume)Oxygen requirementAerobic and microaerophilicTemperature range25 to 45°COptimum temperature37°CHabitatHuman pharyngealIsolationPharynx

Phenotypic analysis {#sec3.2}
-------------------

Strain 122RC15 was a Gram-positive rod, non-motile, non-spore-forming ([Table 1](#tbl1){ref-type="table"}, [Fig. 2](#fig2){ref-type="fig"}), and with mean diameter of 0.35 μm (range 0.3--0.4 μm) and mean length of 0.9 μm (range 0.8--1.0 μm). Colonies were yellow on chocolate agar and approximately 1 mm in diameter. Strain was able to grow under aerobic conditions with or without 5% CO~2~ or microaerophilic conditions between 25 and 45°C after 24 h on Columbia agar with 5% sheep\'s blood, chocolate agar and Müller--Hinton agar. No growth occurred under anaerobic conditions. Strain showed catalase-positive but oxidase-negative activities. The strain was able to grow between 0% and 10% NaCl (weight/volume).Fig. 2(a) Gram staining of *Leucobacter massiliensis* strain 122RC15. (b) Transmission electron microscopy of *Leucobacter massiliensis* strain 122RC15 using TechnaiG2 Cryo device (FEI Company) at an operating voltage of 200 keV. Scale bar: 200 nm.

Biochemical characterization {#sec3.3}
----------------------------

For API ZYM, positive reactions were observed for alkaline phosphatase, esterase, esterase-lipase, leucine arylamidase, valine arylamidase, cysteine arylamidase, acid phosphatase, and naphthol-AS-BI-phosphohydrolase. Negative reactions were addressed for lipase, trypsin, α-chymotrypsin, α-galactosidase, β-galactosidase, β-glucuronidase, α-glucosidase, β-glucosidase, *N*-acetyl-β-glucosaminidase, α-mannosidase and α-fucosidase. Using an API 50 CH strip (bioMérieux), negative reactions were observed for the fermentation of glycerol, erythritol, [d]{.smallcaps}-arabinose, [l]{.smallcaps}-arabinose, [d]{.smallcaps}-ribose, ribose, [d]{.smallcaps}-xylose, [l]{.smallcaps}-xylose, [d]{.smallcaps}-adonitol, methyl-β-[d]{.smallcaps}-xylopyranoside, [d]{.smallcaps}-galactose, [d]{.smallcaps}-glucose, [d]{.smallcaps}-fructose, [d]{.smallcaps}-mannose, [l]{.smallcaps}-sorbose, [l]{.smallcaps}-rhamnose, dulcitol, inositol, [d]{.smallcaps}-mannitol, [d]{.smallcaps}-sorbitol, methyl-α-[d]{.smallcaps}-xylopyranoside, methyl-α-[d]{.smallcaps}-glucopyranoside, *N*-acetylglucosamine, amygdalin, arbutin, esculin, salicin, [d]{.smallcaps}-cellobiose, [d]{.smallcaps}-maltose, [d]{.smallcaps}-lactose, [d]{.smallcaps}-mellibiose, [d]{.smallcaps}-saccharose, [d]{.smallcaps}-trehalose, inulin, [d]{.smallcaps}-melezitose, [d]{.smallcaps}-raffinose, amidon, glycogen, xylitol, gentiobiose, [d]{.smallcaps}-turanose, [d]{.smallcaps}-lyxose, [d]{.smallcaps}-tagatose, [d]{.smallcaps}-fucose, [l]{.smallcaps}-fucose, [d]{.smallcaps}-arabitol, [l]{.smallcaps}-arabitol, potassium gluconate, potassium 2-ketogluconate and potassium-5 ketogluconate. The major fatty acids of strain 122RC15 were branched structures: 15:0 ante-iso (40%); 17:0 ante-iso (38%); 16:0 iso (17%). Moreover, no unsaturated fatty acids were detected. "*Leucobacter massiliensis*" strain 122RC15 was susceptible to penicillin, amoxicillin, amoxicillin/clavulanic acid, ticarcillin, ceftriaxone, imipenem, gentamicin, kanamycin, trimethoprim/sulfamethoxazole, erythromycin, doxycycline, vancomycin, ciprofloxacin and rifampicin, but resistant to teicoplanin, metronidazole, tobramycin, fosfomycin, nitrofuratoin, sulfamethoxazole and colistin.

Genome description and comparisons {#sec3.4}
----------------------------------

The genome is 3 136 406 bp long with 70.96% G+C content ([Table 2](#tbl2){ref-type="table"}). It is composed of 24 scaffolds (composed of 24 contigs). Of the 2846 predicted genes, 2797 were protein-coding genes and 49 were RNAs (two genes are 5S rRNA, one gene is 16S rRNA, one gene is 23S rRNA, 45 genes are tRNA genes). A total of 2100 genes (75.08%) were assigned as putative function (by COGs or by NR blast). In all 113 genes were identified as ORFans (4.04%). The remaining 508 genes were annotated as hypothetical proteins (18.16%). Mobilome, virulence, and toxin-associated or antitoxin-associated genes were found in the genome at 48.73%, 20.49% and 2.82%, respectively. Genes associated with polyketide synthases or non-ribosomal peptide synthetases were found at 0.46%. None of genes were associated with antibiotic resistance. However, there are 12 genomic islands and 311 genes predicted in this strain ([Fig. 3](#fig3){ref-type="fig"}). The size of the genomic islands varied from 4442 bp to 102 553 bp. Most genomic islands 196 genes (64.95%), had unknown protein function. Ninety-five strain-specific genes such as putative internalin protein, sortase A, LPXTG-specific, ABC-type Fe^3+^-siderophore transport system were found in genomic islands. The distribution of genes into COGs functional categories for strain 122RC15 is presented in [Table 3](#tbl3){ref-type="table"} and [Fig. 4](#fig4){ref-type="fig"}. The genome was deposited into GenBank under accession no. MWZD00000000. Genomes of available *Leucobacter* species were compared as shown in [Table 4](#tbl4){ref-type="table"}. Average nucleotide identity between *Leucobacter* genomes showed that strain 122RC15 has similarity with *Leucobacter chironomi* DSM 19883 at 79.42% identity ([Table 5](#tbl5){ref-type="table"}).Fig. 3Genomic islands of *Leucobacter massiliensis* strain 122RC15. Orange and blue lines denote genomic islands predicted by SIGI-HMM and IslandPath/DIMOB, respectively. Red line denotes the genomic locations of all predicted islands.Fig. 4Graphical circular map of *Leucobacter massiliensis* strain 122RC15 chromosome. From outside to centre: outer two circles show open reading frame oriented forward (coloured by the Clusters of Orthologous Groups database categories) and backwards (coloured by Clusters of Orthologous Groups database categories), respectively. Third circle marks tRNA genes (green). Fourth circle shows G+C% content plot. Innermost circle shows GC skew; purple indicates negative values and olive indicates positive values.Table 2Nucleotide content and gene count levels of the genome of strain 122RC15AttributeValue% of totalGenome size (bp)3 136 406100DNA coding (bp)2 840 49190.57DNA G+C (bp)2 225 71570.96Total genes2846100Protein coding genes279798.28RNA genes491.72Genes with function prediction210075.08Genes assigned to Clusters of Orthologous Groups database183265.50Genes with signal peptides32711.69Genes with transmembrane helices69724.92Genes associated with resistant genes00Genes associated with polyketide synthases or non-ribosomal peptide synthetases130.46Genes associated with bacteriocins240.86Genes associated with mobilome136348.73Genes associated with virulence57320.49Genes associated with toxin/antitoxin792.82Genes associated with Pfam-A domains257290Table 3Number of genes associated with the general COGs functional categoriesCodeValue% valueDescriptionJ1686.01TranslationA10.04RNA processing and modificationK1394.97TranscriptionL913.25Replication, recombination and repairB20.07Chromatin structure and dynamicsD230.82Cell cycle control, mitosis and meiosisY00.00Nuclear structureV541.93Defence mechanismsT622.22Signal transduction mechanismsM782.79Cell wall/membrane biogenesisN130.46Cell motilityZ00.00CytoskeletonW10.04Extracellular structuresU240.86Intracellular trafficking and secretionO732.61Post-translational modification, protein turnover, chaperonesX100.36Mobilome: prophages, transposonC1113.97Energy production and conversionG1605.72Carbohydrate transport and metabolismE33411.94Amino acid transport and metabolismF692.47Nucleotide transport and metabolismH933.32Coenzyme transport and metabolismI973.47Lipid transport and metabolismP1515.40Inorganic ion transport and metabolismQ572.04Secondary metabolites biosynthesis, transport and catabolismR1987.08General function prediction onlyS762.72Unknown function--71225.46Not in COGs[^1]Table 4List of *Leucobacter* genomes and their GenBank Accession numberOrganism/NameRef seq accession no.Size (Mb)GC%*Leucobacter* sp. PH1cNZ_AYMV00000000.13.1271.30*Leucobacter* sp. Ag1NZ_LAYO00000000.13.5470.30*Leucobacter* sp. UCD-THUNZ_APJM00000000.13.3270.30*Leucobacter* sp. G161NZ_LOHP00000000.13.5565.30*Leucobacter musarum* subsp*. musarum* CBX152NZ_JHBW00000000.13.4466.80*Leucobacter musarum* subsp. *japonicus* CBX130NZ_JHBX00000000.13.5966.80*Leucobacter celer* subsp*. astrifaciens* CBX151NZ_JHEI00000000.14.1469.10*Leucobacter chironomi* DSM 19883NZ_ATXU00000000.12.9669.90*Leucobacter salsicius* M1-8NZ_AOCN00000000.13.1964.50*Leucobacter chromiiresistens* JG 31NZ_AGCW00000000.13.3768.40*Leucobacter chromiiresistens* NS354NZ_LDRK00000000.12.7970.80*Leucobacter chromiiresistens* DSM 22788NZ_FNKB00000000.13.2270.30*Leucobacter komagatae* VKM ST2845NZ_JXSQ00000000.13.6765.30*Leucobacter massiliensis* 122RC15MWZD000000003.1470.96Table 5Pairwise comparison of *Leucobacter massiliensis* with 13 other species using JS[pecies]{.smallcaps}WS (measures the average nucleotide identity (ANI) based on BLAST+ (ANIb)Genome no.Organism name12345678910111213141*Leucobacter salsicius* M1-8\*75.5676.2176.1175.9774.7175.7574.5373.8874.5575.4873.275.3975.342*Leucobacter chromiiresistens* JG 31\*78.8178.7978.3276.9278.6480.1474.680.259474.2999.9877.883*Leucobacter* sp. UCD-THU\*87.0378.9277.680.6477.474.7577.2978.4974.5378.5779.194*Leucobacter chironomi* DSM 19883\*79.1377.7580.5877.3875.4177.2878.7275.1278.7679.425*Leucobacter* sp. PH1c\*77.6778.9376.8775.3176.9378.2675.478.4178.446*Leucobacter* sp. Ag1\*7775.574.0775.5876.9573.9676.5876.517*Leucobacter celer* subsp. *astrifaciens* CBX151\*77.2174.1477.5577.7173.8477.7679.358*Leucobacter musarum* subsp. *musarum* CBX152\*73.5794.6779.3973.3979.5775.929Leucobacter sp. G161\*73.3174.4479.374.4274.4910*Leucobacter musarum* subsp. *japonicus* CBX130\*79.2473.2179.3575.8811*Leucobacter chromiiresistens* NS354\*74.6494.0278.0412*Leucobacter komagatae* VKM ST2845\*73.9573.7913*Leucobacter chromiiresistens* DSM 22788\*78.114*Leucobacter massiliensis* 122RC15

Moreover, all-against-all BLAST comparison of multiple genomes was performed using coding sequences as shown in [Fig. 5](#fig5){ref-type="fig"}. Strain 122RC15 has the highest protein similarity 43.2% with *L. chironomi* DSM 19883. Homology among *Leucobacter* proteomes ranges from 29.5% to 85.8%.Fig. 5A B[last]{.smallcaps} matrix of an all-against-all protein comparison of 14 *Leucobacter* genomes. Percentages of proteome comparisons were calculated by core genes divided by pan genes between genomes.

Several species of *Leucobacter* have been found to be resistant to chromium [@bib29], [@bib30], [@bib31]. However, strain 122RC15 lacks the chromate transporter (*Chr*) gene. Moreover, salt-tolerance-related genes, such as the ABC-type proline/glycine betaine transport system, were found in this 122RC15 genome, indicating salt-tolerance properties of "*L. massiliensis*". A total of 551 specific genes, including six genes of putative internalin, multidrug-efflux transporter and sarcosine operon, were found in this strain.

Conclusion {#sec4}
==========

On the basis of phenotypic, phylogenetic and genomic analyses (taxonogenomics), we formally propose the creation of "*Leucobacter massiliensis*" sp. nov., which contains the strain 122RC15. This bacterium has been isolated from the pharynx of a pilgrim returning from the 2014 Hajj.

Description of *Leucobacter massiliensis* sp. nov. {#sec4.1}
--------------------------------------------------

"*Leucobacter massiliensis*" name comes from *Massilia*, the ancient Roman name for Marseille, France, where the type strain was isolated. The strain was aerobic, Gram-positive, rod-shaped, non-spore-forming, non-motile. Growth was achieved aerobically between 25 and 45°C after 24 h. Catalase was positive but oxidase was negative. The genome is 3 136 406 bp long and G+C content is 70.3%. The 16S rRNA gene sequence and whole-genome shotgun sequence of *L. massiliensis* strain 122RC15 are deposited in GenBank under Accession numbers LN849775 and MWZD00000000, respectively. The type strain 122RC15 (= DSM 29913 = CSUR P1430) was isolated from the pharynx of a healthy 76-year-old Algerian woman after travelling to the 2014 Hajj.
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[^1]: Abbreviation: COGs, Cluster of Orthologous Groups database.
